Literature DB >> 2630570

Immunological functions and phenotypes of peripheral blood lymphocytes from human T-cell leukemia virus-I carriers.

Y Tanaka1, S Oda, K Nagata, N Mori, H Sakamoto, S Eto, U Yamashita.   

Abstract

We studied immunological functions of peripheral blood lymphocytes (PBL) from human T-cell leukemia virus type I (HTLV-I)-seropositive healthy carriers in vitro. Proliferative responses of PBL to T-cell and B-cell mitogens such as concanavalin A (Con A), pokeweed mitogen (PWM), and Staphylococcus aureus Cowan I (SAC) were moderately impaired in HTLV-I carriers compared with normal controls. Immunoglobulin (Ig)-producing activity of PBL stimulated with B-cell mitogens were also impaired in HTLV-I carriers. However, cytotoxic T-cell activity induced by in vitro culture was not impaired but slightly increased in HTLV-I carriers. Natural killer-cell activity was only slightly decreased. By a flow cytofluorometric analysis of the cell surface phenotypes of PBL, the percentage and the mean fluorescence intensity (MFI) of CD 3-positive cells and CD 4-positive cells were significantly decreased in HTLV-I carriers. The percentage and the MFI of CD 8-positive cells was not changed. The percentage and the MFI of CD 25-positive cells were increased. These results suggest that some immunological abnormalities are already present in HTLV-I carriers and such abnormalities have some roles for the leukemogenesis from the infection of the HTLV-I into adult T-cell leukemia (ATL).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2630570     DOI: 10.1007/bf00918017

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  28 in total

Review 1.  The human T-cell leukemia/lymphotropic retroviruses (HTLV) family: past, present, and future.

Authors:  R C Gallo
Journal:  Cancer Res       Date:  1985-09       Impact factor: 12.701

2.  Immunosuppressive factors from adult T-cell leukemia cells.

Authors:  F Shirakawa; Y Tanaka; S Oda; S Chiba; H Suzuki; S Eto; U Yamashita
Journal:  Cancer Res       Date:  1986-09       Impact factor: 12.701

3.  Development of adult T-cell leukemia-lymphoma (ATL) in two anti-ATL-associated antigen-positive healthy adults.

Authors:  K Kinoshita; S Hino; T Amagasaki; Y Yamada; S Kamihira; M Ichimaru; T Munehisa; Y Hinuma
Journal:  Gan       Date:  1982-10

4.  Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study.

Authors:  Y Hinuma; H Komoda; T Chosa; T Kondo; M Kohakura; T Takenaka; M Kikuchi; M Ichimaru; K Yunoki; I Sato; R Matsuo; Y Takiuchi; H Uchino; M Hanaoka
Journal:  Int J Cancer       Date:  1982-06-15       Impact factor: 7.396

5.  The detection of human T cell leukemia virus proviral DNA and its application for classification and diagnosis of T cell malignancy.

Authors:  K Yamaguchi; M Seiki; M Yoshida; H Nishimura; F Kawano; K Takatsuki
Journal:  Blood       Date:  1984-05       Impact factor: 22.113

6.  Selective alterations in immunoregulatory lymphocyte subsets in early HIV (human T-lymphotropic virus type III/lymphadenopathy-associated virus) infection.

Authors:  J V Giorgi; P G Nishanian; I Schmid; L E Hultin; H L Cheng; R Detels
Journal:  J Clin Immunol       Date:  1987-03       Impact factor: 8.317

7.  Retrovirus-induced expression of interleukin 2 receptors on cells of human B-cell lineage.

Authors:  K Sugamura; M Fujii; N Kobayashi; M Sakitani; M Hatanaka; Y Hinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

8.  A new agglutination test for serum antibodies to adult T-cell leukemia virus.

Authors:  M Ikeda; R Fujino; T Matsui; T Yoshida; H Komoda; J Imai
Journal:  Gan       Date:  1984-10

9.  Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity.

Authors:  O Martínez-Maza; E Crabb; R T Mitsuyasu; J L Fahey; J V Giorgi
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

10.  Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells.

Authors:  T Uchiyama; T Hori; M Tsudo; Y Wano; H Umadome; S Tamori; J Yodoi; M Maeda; H Sawami; H Uchino
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

View more
  5 in total

1.  Antibody responses associated with the graft-versus-leukemia effect in adult T-cell leukemia.

Authors:  Masakatsu Hishizawa; Kazunori Imada; Tomomi Sakai; Momoko Nishikori; Nobuyoshi Arima; Mitsuru Tsudo; Takayuki Ishikawa; Takashi Uchiyama
Journal:  Int J Hematol       Date:  2006-05       Impact factor: 2.490

2.  Enhanced inhibition of lymphocyte activation by Mycobacterium avium complex in human T lymphotrophic virus type I carriers.

Authors:  W Matsuyama; R Kubota; T Hamasaki; A Mizoguchi; F Iwami; J Wakimoto; M Kawabata; M Osame
Journal:  Thorax       Date:  2001-05       Impact factor: 9.139

3.  Concomitant augmentation of CD4+ CD29+ helper inducer and diminution of CD4+ CD45RA+ suppressor inducer subset in patients infected with human T cell lymphotropic virus types I or II.

Authors:  R B Lal; D L Rudolph; D S Schmid; M D Lairmore
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

4.  Phenotypic expression of integrin membrane receptors on spontaneously proliferating CD8 cells in human T-lymphotropic virus type II (HTLV-II)-infected individuals.

Authors:  R B Lal; D L Rudolph; T Rowe; T M Folks
Journal:  J Clin Immunol       Date:  1992-03       Impact factor: 8.317

5.  Reduced T cell response in carcinogen-sensitive Donryu rats compared with carcinogen-resistant DRH rats.

Authors:  S Mise-Omata; T Sugiura; K Higashi; U Yamashita
Journal:  Jpn J Cancer Res       Date:  1999-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.